Drug intelligence / Profile preview

human dental pulp mesenchymal stem cell injection

Development stage
Phase 2
Lead developer
Beijing SH Bio-Tech Corporation
Modality
Stem Cell Therapies → Cell Therapies
Administration
Local Injection
01

Overview

Human Dental Pulp Mesenchymal Stem Cell Injection is an allogeneic stem cell therapy developed by Beijing Sanyouli Heze Biotech, a subsidiary of Eastern Union Stem Cell & Gene Engineering (Vcanbio), in collaboration with Capital Medical University and Peking University Third Hospital. The therapy utilizes mesenchymal stem cells derived from human dental pulp (DPSCs), which are known for their high proliferative capacity and potent immunomodulatory and regenerative properties. The product is primarily being investigated for the treatment of chronic periodontitis, where it is administered via local injection to promote the regeneration of periodontal tissues and modulate local inflammatory responses. Additionally, the candidate is in Phase 2 development for other inflammatory and fibrotic conditions, including psoriasis and paraquat-induced lung injury.

Brand names
JTR-161JTR161JTR 161
Other names
人牙髓间充质干细胞注射液Human Dental Pulp Mesenchymal Stem Cell Injection

Beyond the preview

Go deeper on human dental pulp mesenchymal stem cell injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human dental pulp mesenchymal stem cell injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call